ChiroBlock GmbH

ADC Biotechnology Ltd was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Bioconjugation using our proprietary 'Lock-Release'​ technology involves conjugation of proteins that are immobilised on solid supports, which delivers a number of key product advantages from minimal aggregate formation to minimal residual free drug and enhanced yields. From basic R&D applications through to improved supply economics and product risk management application of our 'Lock-Release'​ platform drives value through better products delivered with greater efficiency.

In addition to technology development, ADC Biotechnology offers a range of technical services, including conjugation (conventional and Lock-Release) to a variety of toxin payloads, toxin-linker design and synthesis and supply of ADCs for proof of concept and toxicology testing.

For more information on our services and Lock Release please visit

www.adcbio.com

Aurora Fine Chemicals is a privately held company that was founded in 1990. As a chemicals R&D supplier we offer chemicals for R&D, drug discovery service, compound libraries and custom synthesis. We have one of the largest collections of 18.1 mln. chemicals available in stock and our docking software delivers hits/leads of very high quality in short time.

Our staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. In our Molecular Modeling Group are professionals specializing in computational drug design. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds. Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.

We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. We offer structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production.

Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available.

Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods.

The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics.

Biopolis, S.L. is a leading microbial biotechnology company based in Valencia (Spain) offering Contract Research and Manufacturing. Our core competences are the isolation, selection, design, characterization, validation and production of microorganisms and cellular metabolites with applications in agrifood, feed, pharmaceutical, chemical and environment industries.

As Tailor-made Biotechnological company, we develop solutions for our clients even if Biopolis has internal R&D research lines.

Prototype projects (i) the selection, validation and production of functional probiotics and starters, (ii) the identification, characterization and process development of functional ingredients, (iii) the overexpression of recombinant protein in microbial systems, (iv) the overproduction of synthesis intermediates and active pharmaceutical ingredients (v) the design of novel processes based on microbial and enzymatic catalysis for bulk chemical production (vi) the selection and production of enzymes and (vii) the revaluation of waste and by-products of industry.

Biopolis facilities spread over 1500 m2, hosting 9 specialized research laboratories distributed in 3 Departments (Agri-food Biotechnology, Microbian Biotechnology and Production capacity of 9000 L fermentation).
We offer omics technologies (transcriptomics, metabolomics, and metagenomics) to guarantee a complete service to our customers.

We support life science organisations by solving their research and development problems.

With extensive background in chemical and pharmaceutical industries our team provides consultancy services covering project management, outsourcing, manufacturing and training.

By going beyond the conventional consultancy model and tackling the chemistry challenges directly we divert compound manufacture and supply risks from our clients. Our undertaking to produce the molecules you need frees your time to focus on other discovery and development objectives.

Our individually tailored solutions address key R&D needs including:

Project management;
Filling the resource and skills gap by providing project management

Synthesis and manufacturing;
Synthesising non-commercial compound and fine chemicals
Helping with developing and producing drug candidates to cGMP

Material supply;
Finding hard-to-find commercial fine chemicals and active drugs

Technology solutions;
Identifying enabling technologies that facilitate drug development

Training;
If you wish to use your scientific, technical, or management expertise to work as independent consultants we provide you with the necessary training to set up your business.
Our course provides step-by-step training for people who have extensive scientific or technical background and have worked in the industry, public sector or academia before and now wish to work as independent consultants.
The course is accredited and is approved by the Royal Society of Chemistry for Continuing Professional Development (CPD).

EDASA Scientific Limited is a Chemistry Contract Research Organization active in Organic Synthetic Chemistry.

Exclusive access to the best Russian brains and facilities.
Cutting-edge thinking.
Progressive research.
A highly experienced and flexible approach.
EDASA delivers innovative compounds and creative solutions with considerable economies of cost and time.

EDASA Scientific provides solutions for:

Medicinal Chemistry Projects
Custom Synthesis
Natural Product Synthesis
Synthetic Pathway Design & Optimization
Compound Isolation/Purification Services
Synthetic Scale up Work & API production
Radio-Labeling
Chemical Waste Management

EDASA Scientific’s R&D site is based in Moscow State University’s (MSU) Science Park. As a result, EDASA Scientific has access to MSU’s facilities, as well as a broad range of scientific instruments for compound characterizations such as X-ray, bidimensional NMR, elementary analyzers, and HPLC. EDASA Scientific has access to talented MSU students and premium Russian scientists to be allocated for our collaborator‘s projects. We are also able to partner with MSU’s biological organizations for project follow-ups in biology.